Decreasing Prescription Copayments May Make You Healthier
A new study indicates that by decreasing prescription co-payments, increased
adherence to drug therapy results for patients with chronic diseases like diabetes.
New Diabetes Drug Could Replace Actos
Takeda Pharmaceutical Co., Japan's biggest drugmaker, sought U.S. approval to sell alogliptin as a once-daily treatment for type-2 diabetes, it said in a statement today. If approved, it will be the Osaka- based company's first new medicine released in the U.S. in more than two years. More...
